New CRC Screening Option Opens the Door for New Conversations

Share this content:
New CRC Screening Option Opens the Door for New Conversations
New CRC Screening Option Opens the Door for New Conversations

As a growing number of Americans face cancer diagnoses, the role of oncology nurses in helping them navigate the journey ahead becomes increasingly important. The nurse-patient relationship has the power to impact patients' quality of life and even clinical outcomes. Although much of the conversation with patients will likely revolve around treatment and follow-up, nurses also have a unique opportunity to create meaningful dialogue about prevention, including talking to patients about cancer screening.

The challenge is that while we know how crucial screening is to early detection, treatment success, and long-term outcomes, patient adherence to screenings is notoriously low. Colorectal cancer (CRC) is a great example of the importance of screening.

Continue Reading Below

The second deadliest form of cancer in the United States — second only to lung cancer — colorectal cancer is expected to kill more than 49,000 people this year.1 The good news is that because of the slow progression of polyps from benign to malignant, the 5-year survival rate when diagnosis is made at an early stage is greater than 90%.2 Even better, if polyps are identified and removed in the precancerous phase, colorectal cancer can be prevented.3

Unfortunately, more than 23 million Americans in the recommended group (50 years and older; earlier for some groups and those with a family history) avoid screening.4 As a result, many cases are not diagnosed until the late stages, when the 5-year survival rate is a mere 12%.2  

Page 1 of 3
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs